SKI Market

Indian Indices

Sensex

83,734.25 283.29
( 0.34%)

Global Indices

Nasdaq

49,542.12 20.18
(0.04%)

Dow Jones

6,863.06 5.89
(0.09%)

Hang Seng

57,141.96 575.47
(1.02%)

Nikkei 225

10,698.60 142.43
(1.35%)

Forex

USD-INR

90.69 0.00
(0.00%)

EUR-INR

107.54 0.00
(0.00%)

GBP-INR

123.68 0.00
(0.00%)

JPY-INR

0.59 0.00
(0.00%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Titan Biotech Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524717

INE150C01011

189.4317315

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

47.74

1177.16

EPS(TTM)

Face Value()

Div & Yield %

29.84

0.14

Back

Raunaq International standalone net profit rises 144.12% in the September 2025 quarter

Nov 14,2025

Net profit of Raunaq International rose 144.12% to Rs 0.83 crore in the quarter ended September 2025 as against Rs 0.34 crore during the previous quarter ended September 2024. Sales rose 124.88% to Rs 9.58 crore in the quarter ended September 2025 as against Rs 4.26 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	9.58	4.26	125
OPM %	0.10	11.27	-
PBDT	0.93	0.37	151
PBT	0.92	0.36	156
NP	0.83	0.34	144

83,734.25 283.29 ( 0.34%)

49,542.12 20.18 (0.04%)

6,863.06 5.89 (0.09%)

57,141.96 575.47 (1.02%)

10,698.60 142.43 (1.35%)

90.69 0.00 (0.00%)

107.54 0.00 (0.00%)

123.68 0.00 (0.00%)

0.59 0.00 (0.00%)